SARA WERTMAN: Open Payments
NPI 1770704439 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 21 payments from 16 companies in 2025. Trend: 2023 $469 · 2024 $471 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $92 |
| GE HEALTHCARE | 2 | $38 |
| Aucta Pharmaceuticals, Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| C2N Diagnostics, LLC | 1 | $25 |
| Neurelis, Inc. | 1 | $24 |
| MDD US Operations, LLC | 1 | $24 |
| ACADIA Pharmaceuticals Inc | 1 | $21 |
| Kedrion Biopharma, Inc. | 1 | $21 |
Products named: QULIPTA, Motpoly XR, REXULTI, PRECIVITYAD2, VALTOCO, DAYBUE, Albuked, QALSODY.
Industry payments across NC — which companies pay providers there.
